Literature DB >> 6329175

Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase.

G B Zavoico, M B Feinstein.   

Abstract

Activation of platelets by thrombin rapidly increases cytoplasmic free calcium, [Ca2+]i, measured by Quin -2, and induces secretion. Stimulators of adenylate cyclase (i.e. PGI2, PGD2, forskolin) suppressed or reversed the increase of [Ca2+]i. Inhibitors of adenylate cyclase (i.e. epinephrine, ADP), added before or after thrombin, counteracted PGI2, PGD2 and forskolin and thereby increased [Ca2+]i and restored secretion. Responses to epinephrine (via alpha-2 adrenoreceptors) and ADP were independent of extracellular Ca2+, but required maintained occupancy of thrombin receptors and intact cAMP-phosphodiesterase activity. These results indicate that cAMP serves as an inhibitory second-messenger that antagonizes the mobilization of Ca2+, an activator second-messenger.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329175     DOI: 10.1016/0006-291x(84)91294-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Comparison of the effects of phorbol 12-myristate 13-acetate and prostaglandin E1 on calcium regulation in human platelets.

Authors:  K Yoshida; F Stark; V T Nachmias
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

2.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

3.  The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.

Authors:  J R Sheu; C R Lee; C C Lin; Y C Kan; C H Lin; W C Hung; Y M Lee; M H Yen
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Receptor-operated channels in human platelets.

Authors:  V A Tkachuk; P V Avdonin; I B Cheglakov; V N Bochkov
Journal:  J Protein Chem       Date:  1989-06

5.  Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.

Authors:  J A Ware; P C Johnson; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  Proceedings of the British Pharmacological Society. London, 17th-19th December, 1984. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

7.  The phosphoprotein that regulates platelet Ca2+ transport is located on the plasma membrane, controls membrane-associated Ca2(+)-ATPase and is not glycoprotein Ib beta-subunit.

Authors:  A Darnanville; R Bredoux; K J Clemetson; N Kieffer; N Bourdeau; S Levy-Toledano; J P Caen; J Enouf
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 8.  The role of free oxygen radicals in the expulsion of primary infections of Nippostrongylus brasiliensis.

Authors:  N C Smith
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  Effects of TRA-418, a novel TP-receptor antagonist, and IP-receptor agonist, on human platelet activation and aggregation.

Authors:  Mitsuko Miyamoto; Naohiro Yamada; Shiho Ikezawa; Michihiro Ohno; Atsushi Otake; Kazuo Umemura; Teruo Matsushita
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

10.  Mechanisms of thrombin-induced modifications of human platelet cytoskeleton.

Authors:  F Sinigaglia; C L Balduini; A Bisio; C Balduini
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.